|
Market Closed -
Nasdaq Stockholm
12:00:00 2026-09-24 EDT
|
5-day change | 1st Jan Change | ||
| 9.300 SEK | -6.06% |
|
-25.90% | -53.03% |
| 09-22 | 16 stocks have so far today hit new 52-week lows on the Stockholm Stock Exchange | FW |
| 09-17 | Annexin Pharmaceuticals Doses First Patient in Expanded Retinal Vein Occlusion Trial | MT |
Stock exchange
Nasdaq Stockholm
ANNX 9.300 kr
-6.06%
234K
kr
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
| ANNX | 9.300SEK | -6.06% | 234K kr | ||
Deutsche Boerse AG
| Q910 | 0.8580EUR | -2.72% | 0 € |
Quotes 5-day view: Annexin Pharmaceuticals AB
Delayed Quote Nasdaq Stockholm
| 2026-09-18 | 2026-09-21 | 2026-09-22 | 2026-09-23 | 2026-09-24 | |
|---|---|---|---|---|---|
| Last | SEK 11.85 | SEK 10.10 | SEK 10.15 | SEK 9.900 | SEK 9.300 |
| Volume | 18,073 | 51,366 | 8,100 | 20,842 | 25,163 |
| Change | -5.58% | -14.77% | +0.50% | -2.46% | -6.06% |
| Opening | SEK 12.65 | SEK 11.95 | SEK 10.40 | SEK 10.10 | SEK 9.980 |
| High | SEK 12.70 | SEK 11.95 | SEK 10.40 | SEK 10.50 | SEK 10.00 |
| Low | SEK 11.50 | SEK 9.860 | SEK 9.660 | SEK 9.600 | SEK 9.000 |
Performance
| 1 day | -6.06% | ||
| 1 week | -25.90% | ||
| Current month | -30.34% | ||
| 1 month | -29.55% | ||
| 3 months | -26.48% | ||
| 6 months | -31.11% | ||
| Current year | -53.03% | ||
| 1 year | -68.37% | ||
| 3 years | -86.68% | ||
| 5 years | -94.97% |
Volumes
marketsDaily volume
25,163
Estimated daily volume
25,163
Avg. Volume 20 sessions
13,364
Daily volume ratio
1.88
Avg. Volume 20 sessions SEK
124,285.2
Avg. Volume 20 sessions USD
12,536.9
Record volume 1
112,969
Record volume 2
88,774
Record volume 3
82,527
Capital turnover ratio
0
Float rotation
0
Basic data
Market Cap (SEK)
69,910,748
Market Cap (USD)
7,052,037
Net sales (SEK)
0
Net sales (USD)
0
Number of employees
4
Sales / Employee (SEK)
0
Sales / Employee (USD)
0
Free-Float
54.31%
Free-Float capitalization (SEK)
38,539,700
Free-Float capitalization (USD)
3,887,577
Average Daily Capital Traded
0.18%
Indicators
Moving average 5 days
10.91
Moving average 20 days
12.8
Moving average 50 days
12.74
Moving average 100 days
12.96
Price spread / (MMA5)
+17.31%
Price spread / (MMA20)
+37.58%
Price spread / (MMA50)
+36.96%
Price spread / (MMA100)
+39.36%
STIM
RSI 9 days
16.42
RSI 14 days
24.29
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -6.06% | -25.90% | -68.37% | -86.68% | 7.05M | |
| -3.30% | +2.97% | +54.99% | +104.15% | 74.18B | |
| -0.12% | -1.63% | +33.14% | +74.86% | 59.55B | |
| +2.71% | -0.84% | -16.39% | +364.46% | 25.84B | |
| +0.81% | +3.58% | +1.01% | -5.14% | 24.73B | |
| -1.05% | +2.58% | +24.27% | -10.32% | 20.87B | |
| -1.70% | -4.15% | +147.82% | +325.69% | 15.32B | |
| +2.15% | +2.06% | +45.57% | +169.79% | 14.06B | |
| -0.43% | -5.32% | -14.46% | +775.94% | 13.12B | |
| +0.04% | -3.00% | +15.76% | +234.69% | 11.85B | |
| Average | -0.69% | -2.84% | +22.33% | +194.74% | 25.95B | |
| Weighted average by Cap. | -0.71% | -0.22% | +34.92% | +160.29% |
Historical Quotes: Annexin Pharmaceuticals AB
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Latest transactions
415d89c3d407e966eef89f3f05e7db6.HmwMbjSWjRRLhoCMa09P7xYivJDFYqKRBvoZ56b5nQs.c15bIFLS3GEO9bXJDhoYmi9Q2fKJDM68f7Nc0c663Gl5G3wbWcHYJgDZwQ
| Date | Price | Volume | Total |
|---|---|---|---|
| 11:23:25 | 9.300 | 54 | 25,163 |
| 11:17:51 | 9.340 | 256 | 25,109 |
| 10:24:43 | 9.400 | 212 | 24,853 |
| 10:17:02 | 9.500 | 20 | 24,641 |
| 10:15:25 | 9.100 | 1,014 | 24,621 |
| 10:15:13 | 9.000 | 706 | 23,607 |
| 10:15:13 | 9.000 | 1,294 | 22,901 |
| 10:13:47 | 9.000 | 50 | 21,607 |
| 10:13:47 | 9.000 | 1,720 | 21,557 |
| 10:13:47 | 9.020 | 1,000 | 19,837 |
Price Extremes
| 1 week | 9 |  | 12.7 |
| 1 month | 9 | | 14.15 |
| Current year | 9 | | 23.6 |
| 1 year | 9 | | 29.8 |
| 3 years | 9 | | 97.6 |
| 5 years | 9 | | 190 |
| 10 years | 9 | | 1,320 |
Monthly variations
Annual variations
| 2026 | -53.03% | ||
| 2025 | -54.27% | ||
| 2024 | +66.54% | ||
| 2023 | -73.95% | ||
| 2022 | -0.20% | ||
| 2021 | -43.50% | ||
| 2020 | +0.57% | ||
| 2019 | +3.53% | ||
| 2018 | -70.94% | ||
| 2017 | -40.00% |
- Stock Market
- Stocks
- ANNX Stock
- Quotes Annexin Pharmaceuticals AB
Select your edition
All financial news and data tailored to specific country editions
